No Radiologist, No Problem: Qure.ai's AI Takes the X-Ray Lead
Qure.ai set out to automate that process, training AI models on a large volume of de-identified clinical images sourced through hospital partnerships. The company now works with over 100 healthcare institutions globally and has built a dataset exceeding 1.5 billion images.
The company's flagship product, qXR, is a tool designed to detect abnormalities in chest X-rays — including signs of tuberculosis — in under 30 seconds. The tool is currently deployed in screening programs across several countries, including the Philippines, where mobile vans equipped with X-ray machines use qXR to produce real-time readings. Before deployment, such scans could take weeks to be interpreted.
In 2021, the World Health Organization formally endorsed Qure.ai's solution as an autonomous tool for TB detection, without the need for human review. Warier describes this as a key inflection point for the company. It is also now the most scaled use-case of autonomous
AI in healthcare
, with the system analyzing between 5 to 10 million X-rays annually.
Qure.ai's path to adoption has not been without challenges. AI used in clinical pathways is considered a medical device, which means every deployment must go through rigorous regulatory approval. The company spent three years obtaining its first FDA clearance in the U.S. and now holds 18 regulatory approvals, including CE certification in Europe. Each submission typically requires data from the local population and independent comparison against certified radiologists.
Warier emphasizes that the role of AI is not to replace physicians but to support them. While automation can handle high-volume, routine imaging, tasks like diagnosis confirmation, treatment planning, and patient communication remain with clinicians. 'AI will be there throughout the patient journey,' he says, 'but it will be an assist.'
Looking ahead, Warier expects AI to take over more foundational tasks in radiology — flagging abnormalities, creating template reports, and improving scan-to-diagnosis times. As India's digital health infrastructure evolves — particularly with the introduction of personal health IDs and medical data interoperability — Warier believes the accuracy and value of AI in healthcare will continue to rise.
Qure.ai is currently active in 90 countries, with a growing presence in low- and middle-income regions where radiology expertise is scarce. The company's approach, Warier says, remains grounded in utility: 'We started by solving a problem nobody else was looking at.'
https://health.economictimes.indiatimes.com/tech-heal
Disclaimer - The above content is non-editorial, and ET Healthworld hereby disclaims any and all warranties, expressed or implied, relating to it, and does not guarantee, vouch for or necessarily endorse any of the content.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Today
21 hours ago
- India Today
Royal Enfield posts 31% growth in July, 88,045 motorcycles sold, exports nearly double
Royal Enfield reported strong momentum in July 2025, registering total sales of 88,045 motorcycles, marking a 31% year-on-year growth compared to 67,265 units sold in July 2024. The brand also recorded a 95% surge in exports, underlining growing global demand for its mid-size and global sales surgeDomestic sales rose by 25%, with 76,254 units sold in India, up from 61,208 units in July last year. International markets saw even stronger traction, as exports nearly doubled to 11,791 units, up from 6,057 units, a clear indicator of the brand's strengthening global (April–July) sales for FY26 stood at 3,53,573 units, up 20% over the 2,94,172 units sold during the same period last fiscal. Domestic YTD sales grew 15% to 3,05,033 units, while exports jumped 72% to 48,540 platform and Hunter 350 fuel momentum Commenting on the performance, B Govindarajan, Managing Director of Eicher Motors Ltd. and CEO of Royal Enfield, said, "We are extremely pleased with the sustained demand momentum across our product portfolio. Our new range of motorcycles on the Sherpa 450 platform, and the new refreshed Hunter 350 are seeing excellent reception both in India and global markets. With strong focus on product innovation, global outreach and community engagement, we are confident of further consolidating our leadership in the mid-size motorcycle segment."Brand and business highlightsHimalayan Odyssey 2025 concludes: Royal Enfield completed the 21st edition of its iconic Himalayan Odyssey on July 15, covering 2,600km across Ladakh, Spiti, and Zanskar. The 18-day ride drew 77 riders from around the world and reached Umling La, the highest motorable pass of off-road collection: The brand introduced a purpose-built off-road collection of premium riding gear, featuring CE Class A certified gravel jackets and trousers, MX Pro gloves, the Defender Pro base layer, and the Escapade DS Edge helmet, targeted at serious off-road to Auto Today Magazine- Ends
News18
a day ago
- News18
Missed Scans To Timely Diagnoses: How AI Is Changing Lung Cancer Care In India
Last Updated: Lung cancer cases are often diagnosed late at advanced stages. With the rise of AI in medicine, early intervention is now possible. For years, lung cancer has been one of the deadliest diagnoses, often caught too late, and treated with few options. In India, a majority of lung cancer cases are diagnosed at advanced stages, making early intervention the exception, not the norm. But now, that tide is beginning to turn, and AI is at the forefront of this transformation. 'AI is helping India move from late-stage panic to early-stage preparedness," says Bhargava Reddy, Chief Business Officer, Oncology at 'It's no longer futuristic, it's working on the ground today," he adds. Most lung cancer cases show no symptoms in the early stages. By the time patients experience breathlessness or persistent coughing, the disease is often advanced. And with a radiologist shortage and fragmented systems, delays are built in. 'Only 3.5%–7.2% of patients are diagnosed early. The rest come in when treatment windows are already shrinking," Reddy adds. AI's Game-Changing Role in Early Diagnosis Of Lung Cancer AI doesn't just interpret scans quickly; it catches abnormalities often missed in early assessments. 'AI's ability to find subtle signs, sometimes before symptoms appear, reshapes the timeline of care entirely," says Reddy. And it's not limited to expensive CTs. AI can scan routine chest X-rays, making advanced detection possible even in rural or under-resourced areas. Screening Made Scalable In India, where LDCT is neither affordable nor accessible for the masses, AI is turning the humble X-ray into a powerful tool. A common misconception is that AI is a tool reserved for high-tech hospitals. In reality, its most transformative impact is unfolding in primary health centres and rural clinics that have long struggled with limited access to specialist care. AI serves as a virtual assistant, helping frontline providers in under-resourced districts detect early signs of lung abnormalities, even without an on-site radiologist. This levels the playing field, enabling timely diagnosis where it was previously out of reach. In states like Goa, AI is already integrated into 11 public health centres, helping screen high-risk populations like smokers and those exposed to urban pollution. 'This is where AI is most transformative, not in high-tech hospitals, but in clinics that never had specialist access," Reddy notes. The WHO has already endorsed AI-supported chest X-ray screening. The next step? Embedding it into national cancer programs. 'Mainstreaming AI as essential, not optional, will be key to delivering timely, data-driven care," says Reddy. AI is not just enhancing lung cancer detection; it's changing when and how we act. By enabling earlier diagnosis, broader reach, and faster decision-making, AI is helping India move from late-stage panic to early-stage preparedness. view comments First Published: August 01, 2025, 13:13 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Time of India
a day ago
- Time of India
UP governor stresses crucial role of Anganwadi centres in development of children
Kannauj (UP): Uttar Pradesh Governor Anandiben Patel on Wednesday emphasised the crucial role of Anganwadi centres in ensuring the holistic development of children during early childhood. Speaking at a public programme here, she highlighted that a child's primary development begins at home under the nurturing care of the mother, an official statement said. "Neglecting nutrition during pregnancy may lead to weakness in the child. Just as a farmer cares for his crops, we must nurture our children with the same dedication," she said. Governor Patel said that nearly 200 types of viruses, including TB and cancer-causing agents, may be present in the body from birth, but can be controlled through a balanced and nutritious diet. Referring to Prime Minister Narendra Modi's resolve to make India TB-free, she said that over four lakh TB patients have been cured in UP alone. The governor lauded the performance of Anganwadi children, stating, "It is commendable that children younger than the age when most hesitate to hold a microphone gave such wonderful presentations." On the occasion, she distributed 100 Anganwadi resource kits, five loan approval letters under the CM Yuva Udyami Yojana, 50 Ayushman cards , nutrition kits to 50 TB patients and certificates under various government schemes to numerous beneficiaries.
